Caribou Biosciences, Inc. Common Stock (CRBU) is a publicly traded Healthcare sector company. As of August 13, 2026, CRBU trades at $1.60 with a market cap of $167.62M and a P/E ratio of -1.15. CRBU moved -5.29% today. Year to date, CRBU is +6.92%; over the trailing twelve months it is -5.03%. Its 52-week range spans $0.66 to $3.54. Analyst consensus is strong buy with an average price target of $8.33. Rallies surfaces CRBU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Caribou Biosciences, Inc. Common Stock (CRBU) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CRBU moved -5.29% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $1.60 |
| Market Cap | $167.62M |
| P/E Ratio | -1.15 |
| EPS | $-1.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.54 |
| 52-Week Low | $0.66 |
| Volume | 899.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.20M |
| Net Income | $-133.22M |
| Gross Margin | 0.00% |
3 analysts cover CRBU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.33.